Document:

Exhibit 10.17

 

September 4, 2015

 

Dear Randall,

 

I am pleased to offer you the position of Chief Accounting Officer, Corporate Controller and Senior Vice President based at our corporate office Lake Forest, IL. Your base salary would be two hundred seventy-five thousand dollars and zero cents ($275,000.00) annually and you would continue to report directly to me.  The effective date of your promotion would be August 3, 2015.

 

You would be able to participate in Akorn’s Performance Incentive Plan.  As Senior Vice President, your annual bonus potential would be forty percent (40%) of base salary subject to plan details and annual Board of Directors approval of payout.

 

You would also be eligible to participate in the Long Term Incentive Compensation (LTIC) Plan reserved for key executives and senior level management which would afford you additional stock option grants and restricted awards on an annual basis.  The total award value is equal to 100% of your annual salary of which, 75% is paid out as stock options and the remainder 25% in the form of restricted shares. Any long-term incentive awards for which you would be eligible would be determined by the Compensation Committee of the Board of Directors.

 

Your benefits would remain unchanged.  Your employment at Akorn would continue to be “at-will”, which means that either you or the Company may terminate employment at any time.  Nothing in this letter should be interpreted as a contract of employment.  In addition, the Employee Confidential Information Agreement and Code of Ethics, which you previously signed, remain fully in effect.

 

Randall, the entire executive team wishes you the best of luck in your new assignment.  Should you have any questions about this offer, or any matter related to your employment at Akorn, please do not hesitate to contact me.

 

May I request that you indicate your acceptance of this opportunity and your understanding of the provisions outlined above by signing below and return to my attention.

 

	
Respectfully,
    	
 
    
	
 
    	
 
    
	
/s/   Raj Rai
    	
 
    
	
 
    	
 
    
	
Raj   Rai
    	
 
    
	
Chief   Executive Officer
    	
 
    
	
 
    	
 
    
	
cc:   Renee Wolf/Vice President, Human Resources
    	
 
    

 

 

I accept this offer of employment and understand the terms and conditions outlined above.

 

	
/s/   Randall Pollard
    	
 
    	
 
    
	
Randall   Pollard
    	
 
    	
DateExhibit 10.1

 

Restricted Stock Unit No.             

 

SYNTA PHARMACEUTICALS CORP.

 

Restricted Stock Unit Award Grant Notice

Restricted Stock Unit Award Grant under the Company’s

2015 Stock Plan

 

	
1.
    	
Name   and Address of Participant:
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
2.
    	
Date   of Grant of
    	
 
    
	
 
    	
Restricted   Stock Unit Award:
    	
January 4,   2016
    
	
 
    	
 
    
	
3.
    	
Maximum   Number of Shares underlying
    	
 
    
	
 
    	
Restricted   Stock Unit Award:
    	
 
    
	
 
    	
 
    	
 
    
	
4.
    	
Vesting   of Award:  The shares subject to this Restricted   Stock Unit Award shall vest in full upon the consummation of a Transaction   which closes on or prior to December 31, 2016 provided that the   Participant is employed by the Company or an Affiliate at the time of the   Transaction or the Participant is terminated by the Corporation other than   for “cause” (as defined in the officer’s Severance and Change of Control   Agreement) prior to the Transaction.
    
	
 
    	
 
    	
 
    
	
 
    	
For   the purposes of this Grant Notice and the accompanying Restricted Stock Unit   Agreement, “Transaction” means, whether   effected in one transaction or a series of related transactions, (a) any   merger, consolidation, reorganization, recapitalization or restructuring,   formation of a joint venture, partnership or other business combination   pursuant to which the business of the Company or any of its subsidiaries or a   substantial portion thereof is acquired by or combined with that of an   another person or entity or group of persons or entities (such person, entity   or group, a “Counterparty”); (b) any acquisition,   directly or indirectly, by a Counterparty of a majority of the capital stock   of the Company or any of its subsidiaries, by way of purchase or any other   means; (c) any acquisition, directly or indirectly, by a Counterparty of   at least 25% of the assets of the Company and its subsidiaries (determined   either on the basis of fair market value or book value); (d) any   acquisition, directly or indirectly, by the Company of a majority of the   capital stock of a Counterparty or any of its subsidiaries, by way of   purchase or any other means; or (e) any acquisition, directly or   indirectly, by the Company of a substantial portion of the assets of a   Counterparty and its subsidiaries (determined either on the basis of fair   market value or book value) for consideration in excess of $20 million. For   purposes of this Grant Notice   and the accompanying Restricted Stock Unit Agreement, a “person” includes any person within the meaning of   Section 13(d)(3) under the Securities Exchange Act of 1934.
    
	
 
    	
 
    	
 
    
	
5.
    	
Termination   of Award:  If the Transaction does not   occur on or prior to December 31, 2016, this Restricted Stock Unit Award   shall not vest, no Shares shall be issued hereunder and this Notice and the   accompanying Restricted Stock Unit Agreement shall terminate and be of no   further force and effect.
    

 

 

The Company and the Participant acknowledge receipt of this Restricted Stock Unit Award Grant Notice and agree to the terms of the Restricted Stock Unit Agreement attached hereto and incorporated by reference herein, the Company’s 2015 Stock Plan and the terms of this Restricted Stock Unit Award as set forth above.

 

	
 
    	
SYNTA PHARMACEUTICALS CORP.
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:
    	
 
    
	
 
    	
Title:
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Participant
    
	
 
    	
 
    
	
ATTACHMENTS: Restricted Stock Unit Agreement and 2015 Stock   Plan
    

 

2

 

SYNTA PHARMACEUTICALS CORP.
 2015 STOCK PLAN

 

RESTRICTED STOCK UNIT AGREEMENT

 

AGREEMENT made as of the date of grant set forth in the Restricted Stock Unit Award Grant Notice between SYNTA PHARMACEUTICALS CORP. (the “Company”), a Delaware corporation, and the individual whose name appears on the Restricted Stock Unit Award Grant Notice (the “Participant”).

 

WHEREAS, the Company has adopted the 2015 Stock Plan (the “Plan”), to promote the interests of the Company by providing an incentive for Employees, directors and Consultants of the Company and its Affiliates;

 

WHEREAS, pursuant to the provisions of the Plan, the Company desires to grant to the Participant restricted stock units (“RSUs”) related to the Company’s common stock, $0.0001 par value per share (“Common Stock”), in accordance with the provisions of the Plan, all on the terms and conditions hereinafter set forth; and

 

WHEREAS, the Company and the Participant understand and agree that any terms used and not defined herein have the meanings ascribed to such terms in the Plan.

 

NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

1.             Grant of Award.  The Company hereby grants to the Participant an award for the number of RSUs set forth in the Restricted Stock Unit Award Grant Notice (the “Award”).  Each RSU represents a contingent entitlement of the Participant to receive one share of Common Stock, on the terms and conditions and subject to all the limitations set forth herein, in the Notice and in the Plan, which is incorporated herein by reference.  The Participant acknowledges receipt of a copy of the Plan.

 

2.             Vesting of Award.

 

(a)           Subject to the terms and conditions set forth in this Agreement and the Plan, the Award granted hereby shall vest as set forth in the Restricted Stock Unit Award Grant Notice and is subject to the other terms and conditions of this Agreement and the Plan.  Upon vesting, the Participant shall be entitled to receive such number of shares of Common Stock equivalent to the number of RSUs specified in the Restricted Stock Unit Award Grant Notice provided that unless otherwise set forth in the Notice, the Participant is employed by the Company or an Affiliate on such vesting date.  Such shares of Common Stock shall thereafter be delivered by the Company to the Participant within five days of the applicable vesting date and in accordance with this Agreement and the Plan.

 

(b)           Except as otherwise set forth in this Agreement and the Notice, if the Participant ceases to be employed for any reason by the Company or an Affiliate (the “Termination”) prior to the vesting condition set forth in the Restricted Stock Unit Award Grant Notice, then as of the date on which the Participant’s employment terminates, all unvested RSUs shall immediately be forfeited to the Company and this Agreement shall terminate and be of no further force or effect.

 

 

3.             Prohibitions on Transfer and Sale.  This Award (including any additional RSUs received by the Participant as a result of stock dividends, stock splits or any other similar transaction affecting the Company’s securities without receipt of consideration) shall not be transferable by the Participant otherwise than (i) by will or by the laws of descent and distribution, or (ii) pursuant to a qualified domestic relations order as defined by the Internal Revenue Code or Title I of the Employee Retirement Income Security Act or the rules thereunder.  Except as provided in the previous sentence, the shares of Common Stock to be issued pursuant to this Agreement shall be issued, during the Participant’s lifetime, only to the Participant (or, in the event of legal incapacity or incompetence, to the Participant’s guardian or representative). This Award shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process.  Any attempted transfer, assignment, pledge, hypothecation or other disposition of this Award or of any rights granted hereunder contrary to the provisions of this Section 3, or the levy of any attachment or similar process upon this Award shall be null and void.

 

4.             Adjustments.  The Plan contains provisions covering the treatment of RSUs and shares of Common Stock in a number of contingencies such as stock splits and Corporate Transactions. Provisions in the Plan for adjustment with respect to this Award and the related provisions with respect to successors to the business of the Company are hereby made applicable hereunder and are incorporated herein by reference.

 

5.             Securities Law Compliance.  The Participant specifically acknowledges and agrees that any sales of shares of Common Stock shall be made in accordance with the requirements of the Securities Act.  The Company currently has an effective registration statement on file with the United States Securities and Exchange Commission with respect to the Common Stock to be granted hereunder.  The Company intends to maintain this registration statement but has no obligation to do so.  If the registration statement ceases to be effective for any reason, Participant will not be able to transfer or sell any of the shares of Common Stock issued to the Participant pursuant to this Agreement unless exemptions from registration or filings under applicable securities laws are available.  Furthermore, despite registration, applicable securities laws may restrict the ability of the Participant to sell his or her Common Stock, including due to the Participant’s affiliation with the Company.  The Company shall not be obligated to either issue the Common Stock or permit the resale of any shares of Common Stock if such issuance or resale would violate any applicable securities law, rule or regulation.

 

6.             Rights as a Stockholder.  The Participant shall have no right as a stockholder, including voting and dividend rights, with respect to the RSUs subject to this Agreement.

 

7.             Incorporation of the Plan.  The Participant specifically understands and agrees that the RSUs and the shares of Common Stock to be issued under the Plan will be issued to the Participant pursuant to the Plan, a copy of which Plan the Participant acknowledges he or she has read and understands and by which Plan he or she agrees to be bound.  The provisions of the Plan are incorporated herein by reference.  In addition, this RSU (and any compensation paid or shares issued pursuant to this Restricted Stock Unit Agreement) is subject to recoupment in accordance with The Dodd—Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company and any compensation recovery policy otherwise required by applicable law.  No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for “good reason” or for a “constructive termination” (or similar term) under any agreement with the Company.

 

2

 

8.             Tax Liability of the Participant and Payment of Taxes.  The Participant acknowledges and agrees that any income or other taxes due from the Participant with respect to  this Award or the shares of Common Stock to be issued pursuant to this Agreement or otherwise sold shall be the Participant’s responsibility.  Without limiting the foregoing, the Participant agrees that if under applicable law the Participant will owe taxes at each vesting date on the portion of the Award then vested the Company shall be entitled to immediate payment from the Participant of the amount of any tax or other amounts required to be withheld by the Company by applicable law or regulation. Any taxes or other amounts due shall be paid through reducing the number of shares of Common Stock entitled to be issued to the Participant on the applicable vesting date in an amount equal to the statutory minimum of the Participant’s total tax and other withholding obligations due and payable by the Company.  Fractional shares will not be retained to satisfy any portion of the Company’s withholding obligation.  Accordingly, the Participant agrees that in the event that the amount of withholding required would result in a fraction of a share being owed, that amount will be satisfied by withholding the fractional amount from the Participant’s paycheck.

 

The Company shall not deliver any shares of Common Stock to the Participant until it is satisfied that all required withholdings have been made.

 

9.             Participant Acknowledgements and Authorizations.

 

The Participant acknowledges the following:

 

(a)           The Company is not by the Plan or this Award obligated to continue the Participant as an Employee, director or Consultant of the Company or an Affiliate.

 

(b)           The Plan is discretionary in nature and may be suspended or terminated by the Company at any time.

 

(c)           The grant of this Award is considered a one-time benefit and does not create a contractual or other right to receive any other award under the Plan, benefits in lieu of awards or any other benefits in the future.

 

(d)           The Plan is a voluntary program of the Company and future awards, if any, will be at the sole discretion of the Company, including, but not limited to, the timing of any grant, the amount of any award, vesting provisions and the purchase price, if any.

 

(e)           The value of this Award is an extraordinary item of compensation outside of the scope of the Participant’s employment or consulting contract, if any.  As such the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.  The future value of the shares of Common Stock is unknown and cannot be predicted with certainty.

 

(f)            The Participant (i) authorizes the Company and each Affiliate and any agent of the Company or any Affiliate administering the Plan or providing Plan recordkeeping services, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant of the Award and the administration of the Plan; and  (ii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth in this Agreement.

 

3

 

10.          Notices.  Any notices required or permitted by the terms of this Agreement or the Plan shall be given by recognized courier service, facsimile, registered or certified mail, return receipt requested, addressed as follows:

 

If to the Company:

 

45 Hartwell Avenue

Lexington, MA 02421

Attn: General Counsel

 

If to the Participant at the address set forth on the Restricted Stock Unit Award Grant Notice or to such other address or addresses of which notice in the same manner has previously been given.  Any such notice shall be deemed to have been given on the earliest of receipt, one business day following delivery by the sender to a recognized courier service, or three business days following mailing by registered or certified mail.

 

11.          Assignment and Successors.

 

(a)           This Agreement is personal to the Participant and without the prior written consent of the Company shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Participant’s legal representatives.

 

(b)           This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.

 

12           Governing Law.  This Agreement shall be construed and enforced in accordance with the laws of the State of Delaware, without giving effect to the conflict of law principles thereof.  For the purpose of litigating any dispute that arises under this Agreement, whether at law or in equity, the parties hereby consent to exclusive jurisdiction in the Commonwealth of Massachusetts and agree that such litigation shall be conducted in the state courts of the Commonwealth of Massachusetts or the federal courts of the United States for the District of Massachusetts, Boston Division.

 

13.          Severability.  If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, then such provision or provisions shall be modified to the extent necessary to make such provision valid and enforceable, and to the extent that this is impossible, then such provision shall be deemed to be excised from this Agreement, and the validity, legality and enforceability of the rest of this Agreement shall not be affected thereby.

 

14.          Entire Agreement.  This Agreement, together with the Plan, constitutes the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.  No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret, change or restrict the express terms and provisions of this Agreement provided, however, in any event, this Agreement shall be subject to and governed by the Plan.

 

15.          Modifications and Amendments; Waivers and Consents.  The terms and provisions of this Agreement may be modified or amended as provided in the Plan.  Except as provided in the Plan, the terms and provisions of this Agreement may be waived, or consent for

 

4

 

the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions.  No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar.  Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent.

 

16.          Section 409A.  The Award of RSUs evidenced by this Agreement is intended to be exempt from the nonqualified deferred compensation rules of Section 409A of the Code as a “short term deferral” (as that term is used in the final regulations and other guidance issued under Section 409A of the Code, including Treasury Regulation Section 1.409A-1(b)(4)(i)), and shall be construed accordingly.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}]]